Report on "Burden of Skin Disease" workshop NIAMS, September 2002

Journal of Investigative Dermatology Symposium Proceedings

Volumn 9, Issue 2, 2004, Pages 111-119

  Qureshi, Abrar A ^a   Freedberg, Irwin ^b   Goldsmith, Lowell ^c   Moshell, Alan ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; COST BENEFIT ANALYSIS; DATA BASE; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; INCIDENCE; INFORMATION PROCESSING; MELANOMA; MORBIDITY; PREVALENCE; PUBLIC HEALTH; QUALITY OF LIFE; SKIN DISEASE; SOCIAL ASPECT; SOCIAL STATUS; TAXONOMY; WORKSHOP;

EID: 1842503111     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1087-0024.2003.09104.x     Document Type: Conference Paper

References (42)

1. Aaronson NK, Ahmedzal S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
2. Atherly A, Culler SD, Becker ER: The role of cost effectiveness analysis in health care evaluation. Q J Nucl Med 44:112-120, 2000
3. Barendregt JJ, Nusselder WJ, Bonneaux L: Global burden of disease [comment]. Lancet 350 (9071):142-143; author reply 144-145, 1997
4. Benton B, Bump J, Seketeli A, Liese B: Partnership and promise: Evolution of the African river-blindness campaigns. Ann Trop Med Parasitol 96 (Suppl 1}: S5-S14, 2002
5. Bergner M, Bobbitt RA, Carter WB, Gilson BS: The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19:787-805, 1981
6. Brooks R: EuroQol: The current state of play. Health Policy 37:53-72, 1996
7. Brown GC, Brown MM, Sharma S: Quality and cost effectiveness in health care: A unique approach. J Ophthal Nurs Technol 19:26-30, 2000
8. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
9. Chen SC, Yeung J, Chren MM: Scalpdex: A quality-of-life instrument for scalp dermatitis. Arch Dermatol 138:803-807, 2002
10. Chren MM, Lasek RJ, Quinn LM, Covinsky KE: Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 108: 103-107, 1997
11. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ: Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. J Invest Dermatol 107:707-713, 1996
12. Deffenbaugh JL: Heatth-care continuum. Health Manpow Manage 20:37-39, 1994
13. Dijkers MP: Individualization in quality of life measurement: Instruments and approaches. Arch Phys Med Rehabil 84 (4 Suppl 2):S3-S14, 2003
14. Emery DD, Schneiderman LJ; Cost-effectiveness analysis in health care. Hastings Cent Rep 19:8-13, 1989
15. Finlay AY: Quality of life assessments in dermatology. Semin Cutan Med Surg 17:291-296, 1998
16. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216, 1994
17. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK: Screening for malignant melanoma: A cost-effectiveness analysis. J Am Acad Dermatol 41 (5 Part 1):738-745, 1999
18. Freedman DM, Dosemeci M, McGlynn K: Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: A composite death certificate based case-control study. Occup Environ Med 59: 257-262, 2002
19. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HD: Melanoma incidence and mortality among US Whites, 1969-1999. JAMA 288:1719-1720, 2002
20. Gilbody SM, House AO, Sheldon T: Routine administration of Health Related Quality of Life (HRQoL) and needs assessment instruments to improve psychological outcome - A systematic review [comment]. Psychol Med 32:1345-1356, 2002
21. Gold MR, Muennig P: Measure-dependent variation in burden of disease estimates: Implications for policy. Med Care 40:260-266, 2002
22. Harlow D, Poyner T, Finlay AY, Dykes PJ: Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 143:979-982, 2000
23. Hickey AM, Bury G, O'Boyte CA, Bradley F, O'Kelly FD, Shannon W: A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. BMJ 313:29-33, 1996
24. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E: The Nottingham Health Profile: Subjective health status and medical consultations. Soc Sci Med A Med Soc 15 (3 Pt 1):221-229, 1981
25. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Grifffith LE, Townsend M: Measuring quality of life in children with asthma. Qual Life Res 5:35-46, 1996
26. Kurwa HA, Finlay AY: Dermatology in-patient management greatly improves life quality. Br J Dermatol 133:575-578, 1995
27. Lasek RJ, Chren MM: Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 134:454-158, 1998
28. Levine MN, Ganz PA: Beyond the devebpment of quality-of-life instruments: Where do we go from here? [comment]. J Clin Oncol 20:2215-2216, 2002
29. Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J, Stratigos J: Children with alopecia areata: Psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 36:678-684, 1997
30. Lopez AD, Murray CC: The global burden of disease, 1990-2020. Nat Med 4:1241-1243, 1998
31. Mathers CD, Shibuya K, Boschi-Pinto C, Lopez AD, Murray CJ: Global and regional estimates of cancer mortality and incidence by site. I. Application of regional cancer survival model to estimate cancer mortality distribution by site. BMC Cancer 2:36, 2002
32. McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental hearth constructs. Med Care 31:247-263, 1993
33. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world. Global Burden of Disease Study [comment]. Lancet 349:1269-1276, 1997
34. O'Brlen BJ, Briggs AH: Analysis of uncertainty in health care cost-effectiveness studies: An introduction to statistical issues and methods. Stat Methods Med Res 11:455-468, 2002
35. O'Hagan A, Stevens JW: Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies. Stat Methods Med Res 11:469-490, 2002
36. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM: A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 32:1109-1126, 1994
37. Severi G, Giles GG, Robertson C, Boyle P, Autier P: Mortality from cutaneous melanoma: Evidence for contrasting trends between populations. Br J Cancer 82:1887-1991, 2000
38. Shaw HM, McCarthy WH, Milton GW: Changing trends in mortality from malignant melanoma. Med J Aust 2:77-80, 1977
39. Smets EM, Garssen B, Cull A, de Haes JC: Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 73:241-245, 1996
40. Taylor R: Small area population disease burden [comment]. Aust N Zeal J Pub Health 25:289-293, 2001
41. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C: Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 56:52-60, 2003
42. Williamson D, Gonzalez M, Finlay AY: The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 15:137-139, 2000